Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer

Sponsor
Nanchong Central Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05514769
Collaborator
(none)
60
1
2
60
1

Study Details

Study Description

Brief Summary

This research is designed to compare proximal gastrectomy anterior anastomosis with pyloroplasty with esophagogastric anastomosis for gastric cancer. Gastroesophageal reflux disease, postoperative quality of life, short term outcomes, and long term outcomes will be compared.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty (GAP)

The reconstruction including esophagogastric anastomosis and pyloroplasty for patients who underwent proximal gastrectomy . The anastomosis locate in the anterior of gastric stump.

Procedure: Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty
The location of the anastomosis in the anterior of the gastric stump. Pyloroplasty is added in the procedure

Active Comparator: Control

The reconstruction including esophagogastric anastomosis and pyloroplasty for patients who underwent proximal gastrectomy . The anastomosis locate in the posterior or side of gastric stump.

Procedure: Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty
The location of the anastomosis in the anterior of the gastric stump. Pyloroplasty is added in the procedure

Outcome Measures

Primary Outcome Measures

  1. Gastroesophagus reflux disease apprised by ph monitoring [6 months]

    Ph monitoring by wireless or wire device

  2. Gastroesophagus reflux disease apprised by questionnaire [6 months]

    PGSAS-45 questionnaire is adopted.

Secondary Outcome Measures

  1. Surgical complications of proximal gastrectomy for gastric cancer [1 year]

    Surgical complications include anastomotic leakage, anastomotic stricture, postoperative bleeding, pleural effusion, et al.

  2. Long-term outcome [5 years]

    Total survival time after proximal gastrectomy for gastric cancer

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages.

  2. Eastern Cooperative Oncology Group performance status of 0 or 1.

  3. Adequate organ function.

Exclusion Criteria:
  1. Patients had distant metastasis.

  2. oesophageal invasion of more than 3 cm.

  3. Borrmann type 4 or large (more than 8 cm) type 3 carcinoma.

  4. Previous chemotherapy or radiation therapy for any other malignancies.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Yunhong Tian Nanchong Sichuan China 637000

Sponsors and Collaborators

  • Nanchong Central Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yunhong Tian, Professor, Nanchong Central Hospital
ClinicalTrials.gov Identifier:
NCT05514769
Other Study ID Numbers:
  • 20220720
First Posted:
Aug 24, 2022
Last Update Posted:
Aug 24, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2022